High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 46, Issue 10, 2011, Pages 1339-1344

  Puig, N ^a   Pintilie, M ^a   Seshadri, T ^a   Al Farsi, K ^a   Franke, N ^a   Keating, A ^a   Kuruvilla, J ^a   Crump, M ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

autologous; elderly; Hodgkin; lymphoma

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOSPORIN; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; MELPHALAN; MORPHINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER SURVIVAL; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COHORT ANALYSIS; DEATH; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SKIN TOXICITY; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HODGKIN DISEASE; HUMANS; MALE; MELPHALAN; MIDDLE AGED; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 80053972813     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.294     Document Type: Article

References (30)

1. Proctor SJ, Rueffer JU, Angus B, Breuer K, Flechtner H, Jarrett R et al. Hodgkin's disease in elderly: current status and future directions. Ann Oncol 2002; 13(suppl 1): 133-137. (Pubitemid 34567417)
2. Landgren O, Algernon C, Axdorph U, Nilsson B, Wedelin C, Porwit-MacDonald A et al. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematologica 2003; 88: 438-444. (Pubitemid 36547130)
3. Weekes CD, Vose JM, Lynch JC, Weisenburger DD, Bierman PJ, Greiner T et al. Nebraska Lymphoma Study Group. Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen. J Clin Oncol 2002; 20: 1087-1093. (Pubitemid 34141854)
4. Macpherson N, Klasa RJ, Gascoyne R, O'Reilly SE, Voss N, Connors JM. Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study. Leuk Lymphoma 2002; 43: 1395-1402. (Pubitemid 34705023)
5. Kim HK, Silver B, Li S, Neuberg D, Mauch P. Hodgkin's disease in elderly patients (X60): clinical outcome and treatment strategies. Int J Radiat Oncol Biol Phys 2003; 56: 556-560. (Pubitemid 36542916)
6. Engert A, Ballova V, Haverkamp H, Pfistner B, Josting A, Du? hmke E et al. Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group. J Clin Oncol 2005; 23: 5052-5060. (Pubitemid 46224012)
7. Brenner H, Gondos A, Pulte D. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood 2008; 111: 2977-2983.
8. Radford JA, Rohatiner AZ, Ryder WD, Deakin DP, Barbui T, Lucie NP et al. ChIVPP/EVA hybrid vs the weekly VAPEC-B regimen for previously untreated Hodgkin's disease. J Clin Oncol 2002; 20: 2988-2994. (Pubitemid 34728894)
9. Horning SJ, Hoppe RT, Breslin S, Bartlett NL, Brown BW, Rosenberg SA. Standford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of prospective clinical trial. J Clin Oncol 2002; 20: 630-637. (Pubitemid 34111368)
10. Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D et al German Hodgkin's Lymphoma Study Group. Standard and increased-dose BEACOPP chemotherapy compared with COPP/ABVD for advanced Hodgkin's disease. N Engl J Med 2003; 348: 2386-2395. (Pubitemid 36682817)
11. Ballova V, Ru? ffer JU, Haverkamp H, Pfistner B, Mu? ller-Hermelink HK, Du? hmke E et al. A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). Ann Oncol 2005; 16: 124-131. (Pubitemid 40124489)
12. Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomized trial. Lancet 2002; 359: 2065-2071. (Pubitemid 34680969)
13. Linch DC, Winfield D, Goldstone AH, Moir D, Hancock B, McMillan A et al. Dose intensification with autologous bonemarrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet 1993; 341: 1051-1054. (Pubitemid 23114397)
14. Jantunen E, Ita? la? M, Juvonen E, Leppa? S, Keskinen L, Vasala K et al. Autologous stem cell transplantation in elderly (460 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis. Bone Marrow Transplant 2006; 37: 367-372. (Pubitemid 43250470)
15. Hosing C, Saliba RM, Okoroji GJ, Popat U, Couriel D, Ali T et al. High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients 465 years of age. Ann Oncol 2008; 19: 1166-1171. (Pubitemid 351801735)
16. Badros A, Barlogie B, Siegel E, Morris C, Desikan R, Zangari M et al. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. Br J Haematol 2001; 114: 600-607. (Pubitemid 32953638)
17. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 1244-1253. (Pubitemid 29162950)
18. Mollee P, Pereira D, Nagy T, Song K, Saragosa R, Keating A et al. Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells in patients with lymphoma. Bone Marrow Transplant 2002; 30: 273-278.
19. Stamatoullas A, Fru , Khalfallah S, Buchonnet G, Contentin N, Bastit D et al. Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age. Bone Marrow Transplant 1997; 19: 31-35. (Pubitemid 27056861)
20. Jantunen E, Mahlamaki E, Nousiainen T. Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (460 years) with non-Hodgkin's lymphoma: comparison with patients o60 years treated with the same protocol. Bone Marrow Transplant 2000; 26: 737-741.
21. Leger CS, Bredeson C, Kearns B, Bence-Bruckler I, Atkins H, Huebsch L. Autologous blood and marrow transplantation in patients 60 years and older. Biol Blood Marrow Transplant 2000; 6: 204-210.
22. de la Rubia J, Saavedra S, Sanz GF, Marti?n G, Moscardo? F, Marti?nez J et al. Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 21-25. (Pubitemid 32124403)
23. Olivieri A, Capelli D, Montanari M, Brunori M, Massidda D, Poloni A et al. Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplant 2001; 27: 1189-1195. (Pubitemid 32600292)
24. Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH et al. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non- Hodgkin's lymphoma in adult 60 years and older: a pilot study. Bone Marrow Transplant 2001; 27: 593-599. (Pubitemid 32401456)
25. Villela L, Sureda A, Canals C, Sanz Jr MA, Martino R, Valca? rcel D et al. Low transplant related mortality in older patients with hematological malignancies undergoing autologous stem cell transplantation. Haematologica 2003; 88: 300-305. (Pubitemid 36358718)
26. Bitran JD, Klein L, Link D, Kosirog-Glowacki J, Stewart C, Raack D et al. High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantationin elderly patients (greater than 65 ears of age) with relapsed large cell lymphoma. Biol Blood Marrow Transplant 2003; 9: 383-388. (Pubitemid 38351809)
27. Buadi FK, Micallef IN, Ansell SM, Porrata LF, Dispenzieri A, Elliot MA et al. Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma. Bone Marrow Transplant 2006; 37: 1017-1022.
28. Jantunen E, Canals C, Rambaldi A, Ossenkoppele G, Allione B, Blaise D. Autologous stem cell transplantation in elderly patients (4 or 60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry. Haematologica 2008; 93: 1837-1842.
29. Zimmermann S, Martens UM. Telomeres, senescence and hematopoietic stem cells. Cell and Tissue Res 2008; 331: 79-90. (Pubitemid 350265486)
30. Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF et al. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2008; 14: 840-846. (Pubitemid 351773161)